Please login to the form below

Not currently logged in
Email:
Password:

Sosei appoints CFO

Andrew Oakley joins the Tokyo-based pharma firm

Sosei Andrew OakleyAndrew Oakley has joined Tokyo-based pharmaceutical firm Sosei as chief financial officer, succeeding Hidetoshi Torami.

Oakley brings a varied corporate finance career to the firm, most recently having served as chief financial officer of Vectura Group.

Prior to this, he held the same title at several other biotech companies, including Actelion and Novimmune.

Peter Bains, chief executive officer of Sosei, said: “Andrew brings a wealth of global corporate finance experience, expertise and leadership with a particularly strong focus in the biotechnology sector.

“I am delighted to welcome him to Sosei as our new chief financial officer and look forward to working with Andrew in the coming years as we seek to build Sosei into a global presence.”

31st January 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics